New Jersey Judge Takes Steps to Conserve Resources of Mirena Lawsuit Litigation
A judge presiding over IUD claims in New Jersey is encouraging counsel in other Mirena lawsuit proceedings to coordinate depositions with the Bergen County litigation, among other efforts to conserve the court’s resources.
According to an Order issued on January 14th, protocols were established for all depositions taken in New Jersey, where 488 Mirena lawsuits have now been filed. Plaintiffs in these cases allege similar complications stemming from the contraceptive implant, which they say Bayer Healthcare Pharmaceuticals failed to adequately warn about in their marketing of the IUD. One of the most common claims is that Mirena can spontaneously migrate away from the uterine wall and perforate the uterus, causing recipients to suffer infection, ectopic pregnancy, organ damage and other serious and debilitating injuries. In many instances, surgeons have allegedly been unable to locate the IUD once it has moved away from the uterus, which may lead to a hysterectomy, in the worst-case scenario. The New Jersey court filing stipulates that steps should be taken to avoid duplicative discovery in the litigation, given the similarities of actions that have been filed against Bayer, and also conserve the resources of the parties involved.
The Mirena lawsuit proceeding underway in New Jersey’s Bergen County Superior Court has scheduled its next Case Management Conference for February 25, 2014 at 2:00 p.m., court documents indicate. There, parties will further discuss matters related to the cases. (In Re: Mirena Litigation; Case No. 297)
Hundreds of Federal Cases Now Filed in New York Mirena Lawsuit Litigation
At least 300 Mirena lawsuits are also pending in a federal litigation established in the U.S. District Court, Southern District of New York. Like in the New Jersey proceeding, women similarly point to Bayer’s long-standing history of overstating benefits of the IUD, which is purportedly designed to remain in place for up to five years, and downplaying its potential for side effects. In 2009, the company received a FDA Warning Letter that took issue with certain promotions citing the implant’s ability to make a woman “look and feel great” and improve her sex life. That same year, the federal agency approved Mirena’s use in the treatment of heavy menstrual bleeding. The IUD originally entered the market in 2000.
Filing a Mirena Lawsuit
Did your IUD spontaneously migrate away from the uterine wall? Contact our attorneys today to find out if you are eligible to file a claim by calling (877) 779-1414.